Mohfouz Ahmed, Hamed Manar, Patel Anshul, Tasnim Shams, Shah Princy
Internal Medicine, The Wright Center for Graduate Medical Education, Scranton, USA.
Oncology, Mansoura University, Faculty of Medicine, Mansoura, EGY.
Cureus. 2022 Feb 15;14(2):e22255. doi: 10.7759/cureus.22255. eCollection 2022 Feb.
Pseudomyxoma peritonei (PMP) is any mucin-producing tumor in the abdomen. If left untreated, it can compress vital abdominal organs. We describe a misleading presentation of disseminated peritoneal adenomucinosis (DPAM) of appendiceal origin. Treatment strategies for PMP vary from watchful waiting to cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) or early postoperative intraperitoneal chemotherapy (EPIC). The rarity of PMP has precluded any randomized studies, and few institutions see sufficient cases to report a series. The purpose of this case report is to contribute to reaching a common consensus on the guidelines of pseudomyxoma peritonei. Recent studies support that cytoreduction followed by HIPEC improves survival in patients with peritoneal carcinomatosis of colorectal origin. Our case report introduced a patient with low-grade appendiceal mucinous neoplasm with visceral peritoneal penetration who underwent surgical debulking with promising results that supports the practice. Our patient has also responded well to adjuvant systemic chemotherapy without hyperthermic intraperitoneal chemotherapy.
腹膜假黏液瘤(PMP)是腹部任何产生黏液的肿瘤。如果不进行治疗,它会压迫腹部重要器官。我们描述了一例阑尾来源的播散性腹膜腺黏液瘤病(DPAM)的误导性表现。PMP的治疗策略从密切观察等待到减瘤手术联合热灌注化疗(HIPEC)或术后早期腹腔内化疗(EPIC)不等。PMP的罕见性使得无法进行任何随机研究,很少有机构能见到足够多的病例来报告系列病例。本病例报告的目的是有助于就腹膜假黏液瘤的指南达成共识。最近的研究支持,减瘤后进行HIPEC可提高结直肠来源腹膜癌患者的生存率。我们的病例报告介绍了一名患有低级别阑尾黏液性肿瘤且侵犯脏腹膜的患者,该患者接受了手术减瘤,结果良好,支持了这种做法。我们的患者对辅助全身化疗反应良好,未进行热灌注化疗。